Paraneoplastic Inflammatory Syndrome as the Sole Presenting Symptom of Angiomatoid Fibrous Histiocytoma in a Pediatric Patient
- 12 August 2026
- journal article
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 73 (10)
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Evidence of Chemoresponsiveness in Unresectable Metastatic Angiomatoid Fibrous HistiocytomaJournal of Pediatric Hematology/Oncology, 2023
- Durable response to crizotinib in metastatic angiomatoid fibrous histiocytoma with EWSR1–CREB1 fusion and ALK overexpressionAnnals of Oncology, 2022
- Tocilizumab Controls Paraneoplastic Inflammatory Syndrome but Does Not Suppress Tumor Growth of Angiomatoid Fibrous HistiocytomaCase Reports in Oncological Medicine, 2021
- Therapeutic response of metastatic angiomatoid fibrous histiocytoma carrying EWSR1‐CREB1 fusion to the interleukin‐6 receptor antibody tocilizumabPediatric Blood & Cancer, 2018
- Angiomatoid fibrous histiocytoma: A case of local recurrence and metastases to loco‐regional lymph nodes that responded to chemotherapyPediatric Blood & Cancer, 2016
- Paraneoplastic Syndrome of Angiomatoid Fibrous Histiocytoma May Be Caused by EWSR1-CREB1 Fusion-induced Excessive Interleukin-6 ProductionJournal of Pediatric Hematology/Oncology, 2015
- Characterization of Metastatic Angiomatoid Fibrous HistiocytomaJournal of Pediatric Hematology/Oncology, 2015
- Angiomatoid fibrous histiocytoma including cases with pleomorphic features analysed by fluorescence in situ hybridisationJournal of Clinical Pathology, 2010
- Angiomatoid Malignant Fibrous HistiocytomaAmerican Journal of Surgical Pathology, 1990
- Angiomatoid malignant fibrous histiocytoma.A distinct fibrohistiocytic tumor of children and young adults simulating a vascular neoplasmCancer, 1979